cromolyn sodium has been researched along with Absence Status in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orozco-Suárez, SA; Rocha, L; Santana-Gómez, CE; Valle-Dorado, MG | 2 |
2 other study(ies) available for cromolyn sodium and Absence Status
| Article | Year |
|---|---|
Sodium cromoglycate reduces short- and long-term consequences of status epilepticus in rats.
Topics: Animals; Cromolyn Sodium; Dentate Gyrus; Disease Models, Animal; Hippocampus; Male; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Status Epilepticus; Time Factors | 2018 |
The mast cell stabilizer sodium cromoglycate reduces histamine release and status epilepticus-induced neuronal damage in the rat hippocampus.
Topics: Analysis of Variance; Animals; Anti-Asthmatic Agents; Anticonvulsants; Cell Count; Chromatography, High Pressure Liquid; Cromolyn Sodium; Disease Models, Animal; Electroencephalography; Fluoresceins; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Histamine; Male; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus | 2015 |